Displaying 1 - 12 of 35
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease with the need for holistic therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

The evolving goals of PBC treatment

Webcasts
View
Immune-Mediated and Cholestatic Diseases

AdvanzPharma: Shifting Paradigms in PBC Management (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Demonstrating clinical outcomes through real- world data

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Questions and answers

Webcasts
View
Metabolism, Alcohol & Toxicity

Navigating MASH patient care

Webcasts
View
Displaying 1 - 12 of 35